Our data thus demonstrate that treatment of some human GBM cells with GSK126 in vitro, results in a reversal of H3K27me3 that allows increased expression of CXCL9 and CXCL10 when induced by IFNγ leading to increased migration of T cells to tumor conditioned medium. The gene discussed is CXCL9; the disease is neoplasm.